Exact Mass: 484.27525840000004

Exact Mass Matches: 484.27525840000004

Found 500 metabolites which its exact mass value is equals to given mass value 484.27525840000004, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Stigmatellin Y

C29H40O6 (484.28247400000004)

Gallopamil

5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)-2-(3,4,5-trimethoxyphenyl)pentanenitrile

C28H40N2O5 (484.29370700000004)

C - Cardiovascular system > C08 - Calcium channel blockers > C08D - Selective calcium channel blockers with direct cardiac effects > C08DA - Phenylalkylamine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Same as: D08009

Goshonoside F1

2-{[(2E)-5-[6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-en-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O8 (484.3036024)

Goshonoside F1 is found in fruits. Goshonoside F1 is a constituent of Rubus foliolosus (Ceylon raspberry). Constituent of Rubus foliolosus (Ceylon raspberry). Goshonoside F1 is found in fruits.

Goshonoside F2

2-({2-hydroxy-5-[(3E)-5-hydroxy-3-methylpent-3-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2H-naphthalen-1-yl}methoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O8 (484.3036024)

Goshonoside F2 is found in fruits. Goshonoside F2 is a constituent of Rubus foliolosus (Ceylon raspberry). Constituent of Rubus foliolosus (Ceylon raspberry). Goshonoside F2 is found in fruits.

Ceanothine D

N-[(10Z)-3-(Butan-2-yl)-5,8-dihydroxy-7-(2-methylpropyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-1-methylpyrrolidine-2-carboximidate

C27H40N4O4 (484.30494000000004)

Ceanothine D is found in tea. Ceanothine D is an alkaloid from the root bark of Ceanothus americanus (New Jersey tea

LysoPA(22:5(4Z,7Z,10Z,13Z,16Z)/0:0)

{3-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyloxy]-2-hydroxypropoxy}phosphonic acid

C25H41O7P (484.25897660000004)

LysoPA(22:5(4Z,7Z,10Z,13Z,16Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(22:5(4Z,7Z,10Z,13Z,16Z)/0:0), in particular, consists of one chain of osbond acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.

LysoPA(22:5(7Z,10Z,13Z,16Z,19Z)/0:0)

{3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyloxy]-2-hydroxypropoxy}phosphonic acid

C25H41O7P (484.25897660000004)

LysoPA(22:5(7Z,10Z,13Z,16Z,19Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(22:5(7Z,10Z,13Z,16Z,19Z)/0:0), in particular, consists of one chain of clupanodonic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.

LysoPG(16:0/0:0)

[(2S)-2,3-dihydroxypropoxy][(2R)-3-(hexadecanoyloxy)-2-hydroxypropoxy]phosphinic acid

C22H45O9P (484.280105)

LysoPG(16:0/0:0) is a lysophosphatidylglycerol. It is a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylglycerols can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPG(16:0/0:0), in particular, consists of one chain of palmitic acid at the C-1 position.

[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] hexadecanoate

[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] hexadecanoic acid

C22H45O9P (484.280105)

Dimerum acid

N-(3-{5-[3-(N,5-dihydroxy-3-methylpent-2-enamido)propyl]-3,6-dioxopiperazin-2-yl}propyl)-N,5-dihydroxy-3-methylpent-2-enamide

C22H36N4O8 (484.2533016)

BioMed 101

7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-8-propyl-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid

C28H36O7 (484.2460906)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D020024 - Leukotriene Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

Darutin

(2R,3R,4S,5S,6R)-2-[[(2R,4aS,4bR,7S,10aS)-7-[(1R)-1,2-dihydroxyethyl]-1,1,4a,7-tetramethyl-3,4,4b,5,6,9,10,10a-octahydro-2H-phenanthren-2-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O8 (484.3036024)

Darutoside is a natural product found in Sigesbeckia orientalis and Indocypraea montana with data available. Darutoside is a diterpenoid isolated from Siegesbeckia[1]. Darutoside is a diterpenoid isolated from Siegesbeckia[1].

[3R-[3alpha,5beta,5aalpha,6alpha(E),7alpha,9alpha,9aalpha]]-5,7-bis(Acetyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-6-yl ester 3-phenyl-2-propenoic acid

C28H36O7 (484.2460906)

Communesin H

C30H36N4O2 (484.2838116)

Salvigreside A

C26H44O8 (484.3036024)

12-Hydroxynerolidol 3-O-beta-D-2-acetylglucoside

C25H40O9 (484.26721900000007)

Angeloyl-(+)-gomisin K3

(4,5,14,15,16-pentamethoxy-9,10-dimethyl-3-tricyclo[10.4.0.02,7]hexadeca-1(16),2,4,6,12,14-hexaenyl) (E)-2-methylbut-2-enoate

Darutoside

C26H44O8 (484.3036024)

Cussoside A

C26H44O8 (484.3036024)

9-Hydroxynerolidol-9-O-beta-D-glucopyranoside-2,6-O-diacetate

C25H40O9 (484.26721900000007)

Pubeside B

C26H44O8 (484.3036024)

Segetalin B

(3S,6S,9S,12S)-6-(1H-indol-3-ylmethyl)-3,9-dimethyl-12-propan-2-yl-1,4,7,10,13-pentazacyclopentadecane-2,5,8,11,14-pentone

C24H32N6O5 (484.2434062)

Segetalin B, a cyclopentapeptide from Vaccaria segetalis, possesses estrogen-like activity[1][2]. Segetalin B, a cyclopentapeptide from Vaccaria segetalis, possesses estrogen-like activity[1][2]. Segetalin B, a cyclopentapeptide from Vaccaria segetalis, possesses estrogen-like activity[1][2].

ardisiaquinone E

C29H40O6 (484.28247400000004)

20-Hydroxytubocapsanolide A

C28H36O7 (484.2460906)

A withanolide that is the 20-hydroxy derivative of tubocapsanolide A. Isolated from Tubocapsicum anomalum, it exhibits cytotoxic activity.

25-Hydroxyhalisulfate 9

proceranolide

C28H36O7 (484.2460906)

(5S,10S,13R,16R,17S,20S,21S,22R,23S,24S)-16,22;21,23-diepoxy-21,24-dihydroxystigmasta-8,14-dien-3,28-dione|16beta,22R;21,23S-diepoxy-21S,24-dihydroxy-5alpha-stigmasta-8,14-diene-3,28-dione|16??,22R;21,23S-Diepoxy-21S,24-dihydroxy-5??-stigmasta-8,14-diene-3,28-dione|vernoanthelcin F

(5S,10S,13R,16R,17S,20S,21S,22R,23S,24S)-16,22;21,23-diepoxy-21,24-dihydroxystigmasta-8,14-dien-3,28-dione|16beta,22R;21,23S-diepoxy-21S,24-dihydroxy-5alpha-stigmasta-8,14-diene-3,28-dione|16??,22R;21,23S-Diepoxy-21S,24-dihydroxy-5??-stigmasta-8,14-diene-3,28-dione|vernoanthelcin F

9-(1H-indol-3-ylmethyl)-6,12-dimethyl-3-propan-2-yl-1,4,7,10,13-pentazacyclopentadecane-2,5,8,11,14-pentone

NCGC00385656-01!9-(1H-indol-3-ylmethyl)-6,12-dimethyl-3-propan-2-yl-1,4,7,10,13-pentazacyclopentadecane-2,5,8,11,14-pentone

C24H32N6O5 (484.2434062)

C26H44O8_7-Hydroxy-4-[(3Z)-5-hydroxy-3-methyl-3-penten-1-yl]-4a,8,8-trimethyl-3-methylenedecahydro-2-naphthalenyl beta-D-mannopyranoside

NCGC00381095-01_C26H44O8_7-Hydroxy-4-[(3Z)-5-hydroxy-3-methyl-3-penten-1-yl]-4a,8,8-trimethyl-3-methylenedecahydro-2-naphthalenyl beta-D-mannopyranoside

C26H44O8 (484.3036024)

Aluminum dimerumic acid [M+Al-2H]

C22H36N4O8 (484.2533016)

C26H44O8_{(1S,2R,4aS,5R,8aS)-2-Hydroxy-5-[(3E)-5-hydroxy-3-methyl-3-penten-1-yl]-1,4a-dimethyl-6-methylenedecahydro-1-naphthalenyl}methyl beta-D-threo-hexopyranoside

NCGC00385231-01_C26H44O8_{(1S,2R,4aS,5R,8aS)-2-Hydroxy-5-[(3E)-5-hydroxy-3-methyl-3-penten-1-yl]-1,4a-dimethyl-6-methylenedecahydro-1-naphthalenyl}methyl beta-D-threo-hexopyranoside

C26H44O8 (484.3036024)

Dimerum acid [M-H2+Fe]

C22H36N4O8 (484.2533016)

9-(1H-indol-3-ylmethyl)-6,12-dimethyl-3-propan-2-yl-1,4,7,10,13-pentazacyclopentadecane-2,5,8,11,14-pentone [IIN-based: Match]

NCGC00385656-01!9-(1H-indol-3-ylmethyl)-6,12-dimethyl-3-propan-2-yl-1,4,7,10,13-pentazacyclopentadecane-2,5,8,11,14-pentone [IIN-based: Match]

C24H32N6O5 (484.2434062)

9-(1H-indol-3-ylmethyl)-6,12-dimethyl-3-propan-2-yl-1,4,7,10,13-pentazacyclopentadecane-2,5,8,11,14-pentone [IIN-based on: CCMSLIB00000845034]

NCGC00385656-01!9-(1H-indol-3-ylmethyl)-6,12-dimethyl-3-propan-2-yl-1,4,7,10,13-pentazacyclopentadecane-2,5,8,11,14-pentone [IIN-based on: CCMSLIB00000845034]

C24H32N6O5 (484.2434062)

9-(1H-indol-3-ylmethyl)-6,12-dimethyl-3-propan-2-yl-1,4,7,10,13-pentazacyclopentadecane-2,5,8,11,14-pentone [IIN-based on: CCMSLIB00000845033]

NCGC00385656-01!9-(1H-indol-3-ylmethyl)-6,12-dimethyl-3-propan-2-yl-1,4,7,10,13-pentazacyclopentadecane-2,5,8,11,14-pentone [IIN-based on: CCMSLIB00000845033]

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-methylbutanoic acid

C21H36N6O5S (484.24677660000003)

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-4-carbamoylbutanamido]-3-methylpentanoic acid

C22H40N6O6 (484.300918)

Pro Lys Gln Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-4-carbamoylbutanamido]-4-methylpentanoic acid

C22H40N6O6 (484.300918)

Hexadecanoic acid, 2-[[(2,3-dihydroxypropoxy)hydroxyphosphinyl]oxy]-1-(hydroxymethyl)ethyl ester

C22H45O9P (484.280105)

16-DEOXOMEXICANOLIDE 16-METHYL ETHER

C28H36O7 (484.2460906)

3-DEOXO-3β-HYDROXYMEXICANOLIDE 16-ENOL ETHER

C28H36O7 (484.2460906)

2,3-DIHYDROISOGEDUNIN

C28H36O7 (484.2460906)

PG(16:0/0:0)

1-hexadecanoyl-sn-glycero-3-phospho-(1-sn-glycerol)

C22H45O9P (484.280105)

17-hydroxyandrostane-3-glucuronide

C25H40O9 (484.26721900000007)

Biotin-XX hydrazide

6-[[6-[[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]-1-oxohexyl]amino]-hexanoic acid, hydrazide

C22H40N6O4S (484.28316000000007)

27:2(5Z,9Z)(6Br)

6-bromo-5Z,9Z-heptacosadienoic acid

C27H49BrO2 (484.2915714)

Ceanothine D

N-[3-Ethyl-3-methyl-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-1-methyl-2-pyrrolidinecarboxamide, 9ci

C27H40N4O4 (484.30494000000004)

Goshonoside F1

2-{[(2E)-5-[6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-decahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O8 (484.3036024)

Goshonoside F2

C30H36N4O2 (484.2838116)

2-ethylhexyl prop-2-enoate,2-methylidenehexanoic acid,methyl 2-methylprop-2-enoate,prop-2-enoic acid

C26H44O8 (484.3036024)

1-(DiphenylMethyl)-4-[(1RS,3E)-4-phenyl-1-[(E)-2-phenylethenyl)-3-buten-1-yl]piperazine

C35H36N2 (484.2878336)

2-Despiperidyl-2-(5-carboxypentylamine) Repaglinide

C27H36N2O6 (484.2573236)

(3R,4R,5S)-4-N-Acetyl(1,1-dimethylethyl)amino-5-N,N-diallylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester monohydrochloride

C26H45ClN2O4 (484.30676800000003)

1,3-Bis[3-(triethoxysilyl)propyl]thiourea

C19H44N2O6SSi2 (484.2458484)

Fentonium

C31H34NO4+ (484.24877040000007)

A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03B - Belladonna and derivatives, plain > A03BB - Belladonna alkaloids, semisynthetic, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

2-[cyclohexyl-[2-[5-(3,4-dimethoxyphenyl)-2-tetrazolyl]-1-oxoethyl]amino]-N-cyclopentylpropanamide

C25H36N6O4 (484.2797896)

Gallopamil

C28H40N2O5 (484.29370700000004)

3-O-(2-O-Palmitoyl-L-glycero-3-phospho)-D-glycerol

C22H45O9P (484.280105)

23-Hydroxytubocapsanolide A

C28H36O7 (484.2460906)

A withanolide that is the 23-hydroxy derivative of tubocapsanolide A. Isolated from Tubocapsicum anomalum, it exhibits cytotoxic activity.

Inflatin B

C29H40O6 (484.28247400000004)

BisMePA(20:5)

(1s,2s,4r,6s,11r,12s,14s,16r,17r,18r,21s)-16-[(2r)-3,4-dimethyl-5-oxo-2h-furan-2-yl]-14,18-dihydroxy-11,17,21-trimethyl-5,15-dioxahexacyclo[12.6.1.0²,¹².0⁴,⁶.0⁶,¹¹.0¹⁸,²¹]henicos-8-en-10-one

(1s,2s,4r,6s,11r,12s,14s,16r,17r,18r,21s)-16-[(2r)-3,4-dimethyl-5-oxo-2h-furan-2-yl]-14,18-dihydroxy-11,17,21-trimethyl-5,15-dioxahexacyclo[12.6.1.0²,¹².0⁴,⁶.0⁶,¹¹.0¹⁸,²¹]henicos-8-en-10-one

C28H36O7 (484.2460906)

(1's,2s,2's,4'r,6's,11'r,12's,14'r,16'r,17'r,18'r,21's)-14',16',18'-trihydroxy-3,4,11',17',21'-pentamethyl-5'-oxaspiro[furan-2,15'-hexacyclo[12.6.1.0²,¹².0⁴,⁶.0⁶,¹¹.0¹⁸,²¹]henicosan]-8'-ene-5,10'-dione

(1's,2s,2's,4'r,6's,11'r,12's,14'r,16'r,17'r,18'r,21's)-14',16',18'-trihydroxy-3,4,11',17',21'-pentamethyl-5'-oxaspiro[furan-2,15'-hexacyclo[12.6.1.0²,¹².0⁴,⁶.0⁶,¹¹.0¹⁸,²¹]henicosan]-8'-ene-5,10'-dione

C28H36O7 (484.2460906)

(1r,3br,4s,5r,5as,9ar,9bs,11as)-5-hydroxy-1-[(2s)-2-hydroxy-5-oxo-2h-furan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O7 (484.2460906)

[(1s,4as,6s,7r,7as)-6,7-dihydroxy-1-[(3-methylbutanoyl)oxy]-4-{[(3-methylbutanoyl)oxy]methyl}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-7-yl]methyl 3-methylbutanoate

C25H40O9 (484.26721900000007)

4-hydroxy-1-(5-hydroxy-2-oxo-5h-furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl acetate

C28H36O7 (484.2460906)

(1s,2s,5s,6r,8s,9r,12s,13r,17s,18r,20r)-6-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-8,17-dihydroxy-6,13-dimethyl-7,19-dioxahexacyclo[10.9.0.0²,⁹.0⁵,⁹.0¹³,¹⁸.0¹⁸,²⁰]henicos-15-en-14-one

(1s,2s,5s,6r,8s,9r,12s,13r,17s,18r,20r)-6-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-8,17-dihydroxy-6,13-dimethyl-7,19-dioxahexacyclo[10.9.0.0²,⁹.0⁵,⁹.0¹³,¹⁸.0¹⁸,²⁰]henicos-15-en-14-one

C28H36O7 (484.2460906)

(1s,2s,5s,6r,9r,12s,13r,17s,18r,20r)-6-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-8,17-dihydroxy-6,13-dimethyl-7,19-dioxahexacyclo[10.9.0.0²,⁹.0⁵,⁹.0¹³,¹⁸.0¹⁸,²⁰]henicos-15-en-14-one

C28H36O7 (484.2460906)